Sun et al.‘s prediction model, which incorporated a radiomics signature and clinical variables, demonstrated potential in forecasting PD-L1 expression in NSCLC patients, achieving areas under the curve (AUC) of 0.829 and 0.848 in the training and validation cohorts, respectively32. Here, CD274 is linked to non-small cell lung carcinoma.